Logo - International Journal of Pharmaceutical Compounding

Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2021 - Volume 25, Number 1
View All Articles in Issue

Abstract:  Intravenous admixture compounding is common practice in most hospitals throughout the world. In this intravenous admixture series, we are covering important and practical topics. This issue presents considerations related to ready-to-use products in preparing/compounding admixtures and in actually compounding ready-to-use preparations in the pharmacy for patient use; most compounded intravenous admixtures are ready-to-use for a specific patient. Considerations include room, refrigerated, and frozen ready-to-use, activated ready-to-use, compounding with ready-to-use, implementing a ready-to-use program, and examples of ready-to-use products, their composition, container size, and packaging.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, drug admixtures, intravenous infusion, parenteral ready to use products, premixed drug mixtures, sterile compounding, compounded sterile preparations, contamination control, diluents, stability, drug compatibility, packaging materials

Related Categories: CANCER AND AIDS, FORMULATIONS, ADVERSE DRUG EVENTS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, UROLOGY/URINARY TRACT

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4878

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products